PharmacovigilanceOfficial
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
Heraeus Medevio has asked customers to quarantine certain Navilyst, Spectrum and Arrow guidewires because coating may detach and enter a patient's bloodstream, FDA's early alert says.
The US Food and Drug Administration has published an early alert on a potentially high-risk device issue involving vascular guidewires from Heraeus Medical Components, which trades as Heraeus Medevio. The company has sent a voluntary recall letter advising customers to remove certain guidewires from use and sale.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA MedWatch ↗
Article written by VigiEye from the official source (FDA MedWatch). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026
Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination
🇺🇸 FDA MedWatch · Fri 20 Nov 2026